These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35411052)

  • 81. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.
    Liu X; Liu S; Tang Y; Pu Z; Xiao H; Gao J; Yin Q; Jia Y; Bai Q
    Neurochem Res; 2021 Jun; 46(6):1514-1539. PubMed ID: 33719004
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Gut and Vagina Microbiota Associated With Estrus Return of Weaning Sows and Its Correlation With the Changes in Serum Metabolites.
    Zhang J; Liu M; Ke S; Huang X; Fang S; He M; Fu H; Chen C; Huang L
    Front Microbiol; 2021; 12():690091. PubMed ID: 34489885
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
    Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
    mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
    Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
    J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.
    Aho VTE; Pereira PAB; Voutilainen S; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    EBioMedicine; 2019 Jun; 44():691-707. PubMed ID: 31221587
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease.
    Chen TJ; Feng Y; Liu T; Wu TT; Chen YJ; Li X; Li Q; Wu YC
    Front Neurosci; 2020; 14():549037. PubMed ID: 33381005
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Probiotics synergized with conventional regimen in managing Parkinson's disease.
    Sun H; Zhao F; Liu Y; Ma T; Jin H; Quan K; Leng B; Zhao J; Yuan X; Li Z; Li F; Kwok LY; Zhang S; Sun Z; Zhang J; Zhang H
    NPJ Parkinsons Dis; 2022 May; 8(1):62. PubMed ID: 35610236
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Associations Among Gut Microbiota, Branched Chain Amino Acids, and Parkinson's Disease: Mendelian Randomization Study.
    Yan Z; Zhao G
    J Parkinsons Dis; 2024; 14(6):1129-1138. PubMed ID: 39177611
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Metagenome-assembled microbial genomes from Parkinson's disease fecal samples.
    Duru IC; Lecomte A; Shishido TK; Laine P; Suppula J; Paulin L; Scheperjans F; Pereira PAB; Auvinen P
    Sci Rep; 2024 Aug; 14(1):18906. PubMed ID: 39143178
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.
    Liu X; Liu Y; Liu J; Zhang H; Shan C; Guo Y; Gong X; Cui M; Li X; Tang M
    Neural Regen Res; 2024 Apr; 19(4):833-845. PubMed ID: 37843219
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's disease.
    Grigoletto J; Miraglia F; Benvenuti L; Pellegrini C; Soldi S; Galletti S; Cattaneo A; Pich EM; Grimaldi M; Colla E; Vesci L
    NPJ Parkinsons Dis; 2023 Oct; 9(1):140. PubMed ID: 37783672
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Interpretable Machine Learning on Metabolomics Data Reveals Biomarkers for Parkinson's Disease.
    Zhang JD; Xue C; Kolachalama VB; Donald WA
    ACS Cent Sci; 2023 May; 9(5):1035-1045. PubMed ID: 37252351
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mechanisms of the
    Li D; You HJ; Hu GJ; Yao RY; Xie AM; Li XY
    Front Nutr; 2022; 9():945356. PubMed ID: 36687704
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
    Xie A; Ensink E; Li P; Gordevičius J; Marshall LL; George S; Pospisilik JA; Aho VTE; Houser MC; Pereira PAB; Rudi K; Paulin L; Tansey MG; Auvinen P; Brundin P; Brundin L; Labrie V; Scheperjans F
    Mov Disord; 2022 Aug; 37(8):1644-1653. PubMed ID: 35723531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.